Acrivon Therapeutics logo

Acrivon Therapeutics Share Price Today

(NASDAQ: ACRV)

Acrivon Therapeutics share price is $5.58 & ₹485.29 as on 6 Mar 2025, 2.30 'hrs' IST

$5.58

0.22

(4.1%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Acrivon Therapeutics share price in Dollar and Rupees. Guide to invest in Acrivon Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Acrivon Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Acrivon Therapeutics share price movements

  • Today's Low: $5.38
    Today's High: $5.75

    Day's Volatility :6.49%

  • 52 Weeks Low: $4.49
    52 Weeks High: $11.90

    52 Weeks Volatility :62.31%

Acrivon Therapeutics (ACRV) Returns

PeriodAcrivon Therapeutics, Inc.Index (Russel 2000)
3 Months
-13.35%
0.0%
6 Months
-30.77%
0.0%
1 Year
17.47%
0.0%
3 Years
-66.47%
-11.6%

Acrivon Therapeutics (ACRV) Key Statistics

in dollars & INR

Previous Close
$5.36
Open
$5.49
Today's High
$5.75
Today's Low
$5.3768
Market Capitalization
$173.7M
Today's Volume
$31.0K
52 Week High
$11.9
52 Week Low
$4.485
Revenue TTM
$0.0
EBITDA
$-84.4M
Earnings Per Share (EPS)
$-2.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-45.95%

How to invest in Acrivon Therapeutics Stock (ACRV) from India?

It is very easy for Indian residents to invest directly in Acrivon Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Acrivon Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Acrivon Therapeutics or ACRV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Acrivon Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Acrivon Therapeutics shares which would translate to 0.156 fractional shares of Acrivon Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Acrivon Therapeutics, in just a few clicks!

Returns in Acrivon Therapeutics (ACRV) for Indian investors in Rupees

The Acrivon Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Acrivon Therapeutics investment value today

Current value as on today

₹1,22,423

Returns

₹22,423

(+22.42%)

Returns from Acrivon Therapeutics Stock

₹17,474 (+17.47%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Acrivon Therapeutics (ACRV)

-13%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Acrivon Therapeutics Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Acrivon Therapeutics

  • RA Capital Management, LLC

    26.79%

  • Perceptive Advisors LLC

    17.22%

  • Sands Capital Ventures, LLC

    6.82%

  • Citadel Advisors Llc

    6.81%

  • BlackRock Inc

    3.04%

  • Wellington Management Company LLP

    2.85%

Analyst Recommendation on Acrivon Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Acrivon Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
15
14
Hold
2
1
1
Sell
0
0
0

Analyst Forecast on Acrivon Therapeutics Stock (ACRV)

What analysts predicted

Upside of 278.34%

Target:

$21.11

Current:

$5.58

Insights on Acrivon Therapeutics Stock (Ticker Symbol: ACRV)

  • Price Movement

    In the last 7 days, ACRV stock has moved up by 4.5%
  • ACRV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 49.0%

Acrivon Therapeutics Technicals Summary

Sell

Neutral

Buy

Acrivon Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Acrivon Therapeutics (ACRV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Acrivon Therapeutics, Inc. logo
-5.58%
-30.77%
17.47%
-66.47%
-66.47%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Acrivon Therapeutics, Inc. logo
NA
NA
NA
-2.62
-0.46
-0.29
NA
6.33
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Acrivon Therapeutics, Inc. logo
Buy
$173.7M
-66.47%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Acrivon Therapeutics

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in Phase II clinical trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response, or DDR, pathways; and ACR-2316, a dual WEE1/PKMYT1 inhibitor. Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts.
Organization
Acrivon Therapeutics
Employees
58
CEO
Dr. Peter Blume-Jensen M.D., Ph.D.
Industry
Healthcare

Management People of Acrivon Therapeutics

NameTitle
Dr. Peter Blume-Jensen M.D., Ph.D.
Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
Ms. Kristina Masson M.B.A., Ph.D.
Co-Founder, Executive VP of Business Operations, Site Head, Treasurer, Secretary & Director
Ms. Mary-Alice Miller J.D.
Chief Legal Officer
Mr. Rasmus Holm-Jorgensen
Chief Financial Officer
Dr. Eric J. Devroe Ph.D.
Chief Operating Officer
Ms. Katharine Peterson CPA
Vice President of Finance & Accounting
Dr. Adam D. Levy M.B.A., Ph.D.
Senior VP and Head of Investor Relations & Corporate Affairs
Mr. Bruce Close
Vice President of Quality & Compliance
Dr. Erick Gamelin M.D., Ph.D.
Chief Development Officer
Dr. Jesper V. Olsen Ph.D.
Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board

Important FAQs about investing in ACRV Stock from India :

What is Acrivon Therapeutics share price today?

Acrivon Therapeutics share price today stands at $5.58, Open: $5.49 ; Previous Close: $5.36 ; High: $5.75 ; Low: $5.38 ; 52 Week High: $11.90 ; 52 Week Low: $4.49.

The stock opens at $5.49, after a previous close of $5.36. The stock reached a daily high of $5.75 and a low of $5.38, with a 52-week high of $11.90 and a 52-week low of $4.49.

Can Indians buy Acrivon Therapeutics shares?

Yes, Indians can invest in the Acrivon Therapeutics (ACRV) from India.

With INDmoney, you can buy Acrivon Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Acrivon Therapeutics at zero transaction cost.

How can I buy Acrivon Therapeutics shares from India?

It is very easy to buy Acrivon Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Acrivon Therapeutics (ACRV) be purchased?

Yes, you can buy fractional shares of Acrivon Therapeutics with INDmoney app.

What are the documents required to start investing in Acrivon Therapeutics stocks?

To start investing in Acrivon Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Acrivon Therapeutics Stock (ACRV)?

Today’s highest price of Acrivon Therapeutics (ACRV) is $5.75.

Today’s lowest price of Acrivon Therapeutics (ACRV) is $5.38.

What is today's market capitalisation of Acrivon Therapeutics?

Today's market capitalisation of Acrivon Therapeutics ACRV is 173.7M

What is the 52 Week High and Low Range of Acrivon Therapeutics Stock (ACRV)?

  • 52 Week High

    $11.90

  • 52 Week Low

    $4.49

What are the historical returns of Acrivon Therapeutics (ACRV)?

  • 1 Month Returns

    -5.58%

  • 3 Months Returns

    -30.77%

  • 1 Year Returns

    17.47%

  • 5 Years Returns

    -66.47%

Who is the Chief Executive Officer (CEO) of Acrivon Therapeutics ?

Dr. Peter Blume-Jensen M.D., Ph.D. is the current Chief Executive Officer (CEO) of Acrivon Therapeutics.

Discover More